Tumour necrosis factors in immune regulation: Everything that's interesting is...New!

Cytokine and Growth Factor Reviews

Volumn 7, Issue 3, 1996, Pages 223-229

  Pasparakis, Manolis ^a   Alexopoulou, Lena ^a   Douni, Eleni ^a   Kollias, George ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN CLASS; LIPOPOLYSACCHARIDE; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIUM; EMBRYOLOGY; FETUS DEVELOPMENT; GENETICS; GERMINAL CENTER; HISTOLOGY; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOREGULATION; INFECTION; INFLAMMATION; LYMPH FOLLICLE; LYMPH NODE; LYMPHOID TISSUE; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; SHORT SURVEY; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; HYPERSENSITIVITY; LYMPH NODES; LYMPHOID TISSUE; MICE; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 0030265356     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(96)00031-7     Document Type: Short Survey

References (55)

1. 1. Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988, 53, 45-53.
2. 2. Vassali P. The pathophysiology of tumour necrosis factor. Ann Rev Immunol 1992, 10, 411-452.
3. 3. Paul NL, Ruddle NH. Lymphotoxin. Ann Rev Immunol 1988, 6, 407-438.
4. 4. Browning JL, Ngamek A, Lawton P, et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72, 847-856.
5. 5. Crowe PD, VanArsdale TL, Walter BN, et al. Lymphotoxin-beta-specific receptor. Science 1994, 264, 707-710.
6. 6. Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995, 5, 392-399.
7. 7. Erikstein BK, Smeland EB, Blomhoff HK, et al. Independent regulation of 55-kDa and 75-kDa tumour necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 1991, 21, 1033-1037.
8. 8. Tartaglia LA, Goeddel DV, Renolds C, et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumour necrosis factor receptor. J Immunol 1993, 151, 4637-4641.
9. 9. Engelmann H, Holtman H, Brakebusch C, et al. Antibodies to a soluble form of a tumour necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990, 265, 14497-14504.
10. 10. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumour necrosis factor receptor. J Exp Med 1990, 171, 415-426.
11. 11. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. The two different receptors for tumour necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991, 88, 9292-9296.
12. 12. Grell M, Douni E, Wajant H, et al. The transmembrane form of tumour necrosis factor is the prime activating ligand of the 80 kDa tumour necrosis factor receptor. Cell 1995, 83, 793-802.
13. 13. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor Nature 1995, 377, 348-351.
14. 14. Keffer J, Probert L, Georgopoulos S, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991, 10, 4025-4031.
15. 15. Probert L, Keffer J, Corbella P, et al. Wasting, ischaemia and lymphoid abnormalities in mice expressing T cell targeted human tumour necrosis factor transgenes. J Immunol 1993, 151, 1984-1906.
16. 16. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumour necrosis factor α. Proc Natl Acad Sci USA 1995, 92, 11294-11298.
17. 17. Beutler B, Milsark JW, Cerami AC. Passive immunisation against cachectin/tumour necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229, 869-891.
18. 18. Freudenberg MA, Galanos C. Tumour necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 1991, 59, 2110-2115.
19. 19. Lesslauer W, Tabuchi H, Gentz R. et al. Recombinant soluble tumour necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immun 1991, 21, 2883-2886.
20. 20. Ashkenazi A, Marsters SA, Capon DJ, et al. Protection against endotoxic shock by tumour necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 1991, 88, 10535-10539.
21. 21. Pfeffer K, Matsuyama T, Kunding TM, et al. Mice deficient for the 55 kD tumour necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73, 457-467.
22. 22. Rothe J, Lesslauer W, Loetscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364, 798-802.
23. 23. Erickson SL, de Sauvage FJ, Kikly K, et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2 deficient mice. Nature 1994, 372, 560-563.
24. 24. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184, (in press).
25. 25. Li P, Allen H, Banerjee S, et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995, 80, 401-411.
26. 26. Kaufman SHE. Immunity to intracellular bacteria. Ann Rev Immunol 1993, 11, 129-163.
27. 27. Conlan JW, North RJ. Neutrophils are essential for early anti-Listerial defence in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 1994, 179, 259-268.
28. 28. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumour necrosis factor are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993, 90, 3725-3729.
29. 29. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: A T-cell-independent pathway of macrophage activation, definded in the scid mouse. Immunol Rev 1991, 124, 5-24.
30. 30. Dalton DK, Pitts MS, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259, 1739-1742.
31. 31. Huang S, Hendricks W, Althage A, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993, 259, 1742-1745.
32. 32. Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumour necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995, 86, 4184-4193.
33. 33. Macatonia SC, Edwards AJ, Knight SC. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 1986, 59, 509-514.
34. 34. Macatonia SC, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localisation of antigen on lymph node dendritic cells after exposure to the contact sensitiser fluorescein isothiocyanate. J Exp Med 1987, 166, 1654-1667.
35. 35. Kinnaird A, Peters SW, Foster JR, Kimber I. Dendritic cell accumulation in the draining lymph nodes during the induction phase of contact allergy in mice. Int Archs Allergty Appl Immun 1989, 89, 202-210.
36. 36. Kimber I, Kinnaird A, Peters SW, Mitchell JA. Correlation between lymphocyte proliferative responses and dendritic cell migration in regional lymph following skin painting with contact-sensitising agents. Int Archs Alergy Appl Immun 1990, 93, 47-53.
37. 37. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991, 9, 271-296.
38. 38. Cumberbatch M, Kimber I. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitisation. Immunology 1995, 84, 31-35.
39. 39. Cumberbatch M, Kimber I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhan's cell migration. Immunology 1992, 75, 257-263.
40. 40. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumour necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991, 173, 673-679.
41. 41. Bromberg JS, Chavin KD, Kunkel SL. Anti-tumour necrosis factor antibodies suppress cell-mediated immunity in vivo. J Immunol 1992, 148, 3412-3417.
42. 42. Kurimoto I, Streilein JW. cis-Urocanic suppression of contact hypersensitivity induction is mediated via tumour necrosis factor-α. J Immunol 1992, 148, 3072-3078.
43. 43. Kondo S, Wang B, Fujisawa H, et al. Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J Immunol 1995, 155, 3801-3805.
44. - T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990, 144, 4121-4128.
45. 45. De Togni P, Goellner J, Ruddle NH, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264, 703-707.
46. 46. Mariathasan S, Matsumoto M, Baranyay F, Kanagawa O, Chaplin D. Absence of lymph nodes in lymphotoxin-α (LTα)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J Inflammation 1995, 45, 72-78.
47. 47. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon J, Chaplin D. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centres. Science 1996, 271, 1289-1291.
48. 48. Neumann B, Luz A, Pfeffer K, Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55 kD receptor for tumor necrosis factor. J Exp Med 1996, 184, 259-264.
49. 49. Le Hir M, Bluethmann H, Kosco-Vilbois MH, et al. Differentiation of follicular dendritic cells and full antibody responses require tumour necrosis factor receptor-1 signalling. J Exp Med 1996, 183, 2367-2372.
50. 50. Neumann B, Machleidt T, Lifka A, et al. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 1996, 156, 1587-1593.
51. 51. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal centre formation. Immunity 1994, 1, 167-178.
52. 52. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994, 1, 423-431.
53. 53. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996, 93, 221-225.
54. 54. Leprince C, Cohen-Kaminsky S, Berrih-Aknin S, et al. Thymic B cells from myasthenia gravis patients are activated B cells. J Immunol 1990, 145, 2115-2122.
55. 55. Kratz A, Campos-Neto A, Hanson MS, Ruddle N. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996, 183, 1461-1472.